[Cognitive behavioral therapy for chronic insomnia]
Małgorzata Fornal-Pawłowska1, Waldemar Szelenberger
1Katedra i Klinika Psychiatryczna WUM Kierownik.
Psychiatria Polska
|July 30, 2013
Summary
Cognitive Behavioral Therapy for Insomnia (CBT-I) significantly improved sleep quality and daytime functioning in chronic insomnia patients. These benefits were sustained long-term, with most patients showing clinically meaningful improvement.
Area of Science:
- Sleep Medicine
- Behavioral Therapy
- Psychiatry
Background:
- Chronic insomnia significantly impacts quality of life and daytime functioning.
- Cognitive Behavioral Therapy for Insomnia (CBT-I) is a non-pharmacological treatment approach.
- Evaluating CBT-I's efficacy in a controlled study is crucial for understanding its therapeutic potential.
Purpose of the Study:
- To assess the effectiveness of Cognitive Behavioral Therapy for Insomnia (CBT-I) in treating chronic insomnia.
- To compare sleep parameters and psychological outcomes in insomnia patients treated with CBT-I versus healthy controls.
- To determine the long-term sustainability of CBT-I treatment effects.
Main Methods:
- A randomized controlled trial involving 51 chronic insomnia patients and 51 matched healthy controls.
- CBT-I was administered in 6 group sessions.
- Standardized questionnaires including the Athens Insomnia Scale (AIS) and Beck Depression Inventory (BDI) were used for outcome assessment.
Main Results:
- CBT-I significantly improved all measured sleep parameters, including sleep latency, efficiency, and quality.
- Insomnia patients showed reduced depression and anxiety symptoms, and improved daytime functioning post-treatment.
- Improvements were maintained at a 3-month follow-up, with patients nearing control group levels in several domains.
Conclusions:
- Cognitive Behavioral Therapy for Insomnia (CBT-I) offers a sustained and clinically meaningful improvement for chronic insomnia.
- CBT-I effectively enhances both nocturnal sleep and overall daytime functioning.
- The treatment demonstrates long-term efficacy, making it a valuable therapeutic option.
More Related Videos
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Related Concept Videos
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...